Related Experiment Video

Updated: Jun 18, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.9K

Rabenosyn-5 suppresses non-small cell lung cancer metastasis via inhibiting CDC42 activity

Xiong Guo1, Bin Mu2, Lin Zhu3,4

  • 1Department of Colorectal and Anal Surgery, Xiangya Hospital, Central South University, 410008, Changsha, China.

Cancer Gene Therapy
|July 29, 2024
PubMed

Insights

Rabenosyn-5 (Rbsn) inhibits lung cancer metastasis by regulating cytoskeleton remodeling. Akt-mediated phosphorylation of Rbsn reduces its inhibitory effect, promoting cancer progression.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Mechanisms

Background:

  • Metastasis is the leading cause of lung cancer mortality.
  • Cytoskeleton remodeling is critical for cancer cell migration and invasion.
  • Regulatory mechanisms of intracellular trafficking proteins in metastasis are not fully understood.

Purpose of the Study:

  • To identify novel regulators of cytoskeleton remodeling in lung cancer metastasis.
  • To elucidate the role of Rabenosyn-5 (Rbsn) in lung cancer progression.
  • To investigate the interaction between Rbsn, CDC42, and Akt signaling.

Main Methods:

  • Identification of Rbsn as a filopodia formation inhibitor.
  • Investigation of Rbsn's interaction with CDC42 and its GTPase activating protein (GAP) activity.
  • Analysis of Akt-mediated phosphorylation of Rbsn at Thr253.
  • Correlation of Rbsn expression levels with lung cancer patient prognosis.

Main Results:

  • Rabenosyn-5 (Rbsn) inhibits filopodia formation and lung cancer metastasis.
  • Rbsn acts as a GTPase activating protein (GAP) for CDC42, suppressing its activity.
  • Akt phosphorylation of Rbsn at Thr253 abrogates its inhibitory function on CDC42.
  • Reduced Rbsn expression in lung cancer correlates with poor prognosis.

Conclusions:

  • Rbsn functions as a tumor suppressor by inhibiting lung cancer metastasis.
  • The Rbsn-CDC42 pathway is a critical regulator of cytoskeleton dynamics in cancer.
  • Akt-mediated regulation of Rbsn offers a potential therapeutic target for lung cancer.

More Related Videos

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.2K
The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

111.5K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K